Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6AAR

Crystal structure of DAPK1 in complex with purpurin

Summary for 6AAR
Entry DOI10.2210/pdb6aar/pdb
DescriptorDeath-associated protein kinase 1, Purpurin (3 entities in total)
Functional Keywordsdeath-associated protein kinase 1, serin/threonine protein kinase, hydrolase, transferase
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight34052.61
Authors
Yokoyama, T.,Mizuguchi, M. (deposition date: 2018-07-19, release date: 2019-07-24, Last modification date: 2024-03-27)
Primary citationYokoyama, T.,Wijaya, P.,Kosaka, Y.,Mizuguchi, M.
Structural and thermodynamic analyses of interactions between death-associated protein kinase 1 and anthraquinones.
Acta Crystallogr D Struct Biol, 76:438-446, 2020
Cited by
PubMed Abstract: Death-associated protein kinase 1 (DAPK1) is a serine/threonine protein kinase that regulates apoptosis and autophagy. DAPK1 is considered to be a therapeutic target for amyloid-β deposition, endometrial adenocarcinomas and acute ischemic stroke. Here, the potent inhibitory activity of the natural anthraquinone purpurin against DAPK1 phosphorylation is shown. Thermodynamic analysis revealed that while the binding affinity of purpurin is similar to that of CPR005231, which is a DAPK1 inhibitor with an imidazopyridazine moiety, the binding of purpurin was more enthalpically favorable. In addition, the inhibition potencies were correlated with the enthalpic changes but not with the binding affinities. Crystallographic analysis of the DAPK1-purpurin complex revealed that the formation of a hydrogen-bond network is likely to contribute to the favorable enthalpic changes and that stabilization of the glycine-rich loop may cause less favorable entropic changes. The present findings indicate that purpurin may be a good lead compound for the discovery of inhibitors of DAPK1, and the observation of enthalpic changes could provide important clues for drug development.
PubMed: 32355040
DOI: 10.1107/S2059798320003940
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.95 Å)
Structure validation

227344

건을2024-11-13부터공개중

PDB statisticsPDBj update infoContact PDBjnumon